Mercer Global Advisors Inc Charles River Laboratories International, Inc. Transaction History

Mercer Global Advisors Inc

  • $58.7 Billion
  • Q3 2025

A detailed history of Mercer Global Advisors Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 6,236 shares of CRL stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,236
Previous 3,013 106.97%
Holding current value
$1.05 Million
Previous $457,000 113.35%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$145.57 - $178.99 $469,172 - $576,884
3,223 Added 106.97%
6,236 $975,000
Q2 2025

Aug 14, 2025
BUY
$99.75 - $151.89 $4,089 - $6,227
41 Added 1.38%
3,013 $457,000
Q1 2025

May 15, 2025
BUY
$150.52 - $190.14 $78,420 - $99,062
521 Added 21.26%
2,972 $447,000
Q4 2024

Feb 14, 2025
SELL
$178.58 - $220.69 $340,552 - $420,855
-1,907 Reduced 43.76%
2,451 $452,000
Q3 2024

Nov 13, 2024
BUY
$187.96 - $245.29 $61,462 - $80,209
327 Added 8.11%
4,358 $858,000
Q2 2024

Aug 12, 2024
BUY
$206.39 - $268.73 $355,197 - $462,484
1,721 Added 74.5%
4,031 $832,000
Q1 2024

May 15, 2024
BUY
$203.52 - $273.43 $42,739 - $57,420
210 Added 10.0%
2,310 $626,000
Q4 2023

Feb 14, 2024
BUY
$164.52 - $238.84 $23,526 - $34,154
143 Added 7.31%
2,100 $497,000
Q3 2023

Nov 13, 2023
BUY
$194.44 - $217.61 $55,804 - $62,454
287 Added 17.19%
1,957 $384,000
Q2 2023

Aug 14, 2023
SELL
$183.71 - $210.25 $42,988 - $49,198
-234 Reduced 12.29%
1,670 $351,000
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $44,134 - $59,781
230 Added 13.74%
1,904 $384,000
Q4 2022

Feb 08, 2023
SELL
$197.11 - $250.07 $5,913 - $7,502
-30 Reduced 1.76%
1,674 $365,000
Q3 2022

Nov 15, 2022
SELL
$182.44 - $250.54 $14,047 - $19,291
-77 Reduced 4.32%
1,704 $335,000
Q2 2022

Aug 10, 2022
BUY
$204.13 - $302.4 $45,520 - $67,435
223 Added 14.31%
1,781 $381,000
Q1 2022

May 10, 2022
SELL
$255.51 - $362.11 $318,876 - $451,913
-1,248 Reduced 44.48%
1,558 $442,000
Q4 2021

Feb 04, 2022
BUY
$351.38 - $448.68 $204,854 - $261,580
583 Added 26.23%
2,806 $1.06 Million
Q3 2021

Nov 10, 2021
SELL
$372.64 - $458.3 $6,707 - $8,249
-18 Reduced 0.8%
2,223 $917,000
Q2 2021

Aug 10, 2021
BUY
$294.17 - $371.65 $436,842 - $551,900
1,485 Added 196.43%
2,241 $829,000
Q1 2021

May 11, 2021
BUY
$249.67 - $299.48 $188,750 - $226,406
756 New
756 $219,000

Others Institutions Holding CRL

# of Institutions
644
Shares Held
51.6M
Call Options Held
194K
Put Options Held
174K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email